期刊
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
卷 65, 期 50, 页码 10915-10924出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jafc.7b03931
关键词
fucoxanthin; fucoxanthinol; adipocytes; browning; lipolysis
资金
- National Center For Complementary & Integrative Health of the National Institutes of Health [P50AT002776]
- National Institutes of Health [T32 A T004094]
- COBRE center grant from the National Institutes of Health [NIH8 1P30GM118430-01]
- Office of Dietary Supplements of the National Institutes of Health [P50AT002776]
- National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]
- NORC center grant from the National Institutes of Health [P30DK072476]
Rodent studies suggest that the antiobesity effects of fucoxanthin relate to activation of brown fat and conversion of white adipocytes to the brown phenotype. To evaluate the browning effect in human adipocytes, we investigated the genes involved in browning and measured the oxygen consumption rate (OCR). Data were analyzed by one way ANOVA. Relative to control, fucoxanthinol (1 mu M, 0.1 mu M, 0.01 mu M, 1 nM, 0.1 nM), the metabolite present in human plasma, stimulated lipolysis acutely (mean +/- SEM: 4.2 +/- 0.8, 3.1 +/- 0.6, 4.1 +/- 0.9, 3.8 +/- 0.7, 3.8 +/- 0.7, respectively, p < 0.01). There was no effect on OCR or the mRNA expression of UCP1, CPT-1 beta, and GLUT4, the genes associated with browning of adipose tissue, when human adipocytes were treated with fucoxanthin or fucoxanthinol. -mRNA expression of PGC-1 alpha, PPAR alpha, PPAR gamma, PDK4, FAS, and the lipolytic enzymes was not significantly altered by fucoxanthinol treatment (p > 0.05). Thus, in human adipocytes, fucoxanthin and its metabolite do not stimulate conversion of white adipocytes to the brown phenotype.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据